Semaglutide is a GLP-1 receptor agonist that mimics the GLP-1 hormone your body naturally produces after eating. Semaglutide works by reducing appetite, slowing gastric emptying, and regulating blood sugar — addressing the biological drivers of weight gain that diet and exercise alone often cannot overcome. Clinical trials demonstrated an average weight loss of 15% of body weight, making it one of the most effective medical weight loss tools available.
160x140px
Reduces Appetite
Acts on GLP-1 receptors in the brain's appetite centers — reducing hunger signals and cravings, particularly for high-calorie foods.
Slows Gastric Emptying
Food stays in the stomach longer — extending fullness after meals and naturally reducing portion sizes without effort.
Regulates Blood Sugar
Stimulates insulin release when blood sugar is elevated and suppresses glucagon — improving glycemic control.
Addresses Root Biology
Targets the hormonal and neurological drivers of weight gain — making sustained weight loss biologically achievable.
Full width ~110px
⚖️ Weight Loss
~15% body weight reduction in clinical trials
🩸 Blood Sugar
Improved insulin sensitivity and glucose control
❤️ Heart Health
Reduces cardiovascular risk factors
🔥 Visceral Fat
Targets dangerous belly fat specifically
💊 Cravings
Decreased appetite for high-calorie foods
⚡ Energy
Improved energy as metabolic health improves
😴 Sleep
Weight loss improves sleep quality and apnea
🦴 Joint Relief
Reduced joint pain from lower body weight
Full width ~100px
200px wide
Full width ~90px
Important before your treatment:
Full width ~90px
Disclaimer: This handout is for educational purposes only and does not constitute medical advice. Semaglutide therapy should be administered under the supervision of a licensed healthcare provider. This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Individual results vary. Disclose all medical conditions and medications to your provider before beginning any new therapy.